Short answer
Concentra Group Holdings Parent, Inc. (CON) filed an 8-K current report with the SEC on April 14, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Chief Medical Officer Dr. John Anderson retiring effective December 31, 2026.
Concentra Group Holdings Parent, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Chief Medical Officer Dr. John Anderson retiring effective December 31, 2026
- Expected consulting agreement to support transition of medical leadership responsibilities
- Extended transition period may reduce near-term operational disruption for Concentra
Item 7.01 · Regulation FD Disclosure
- Item 7.01 provides Regulation FD information, but this excerpt contains only standard “furnished, not filed” legal language
- No investor-impacting operating, financial, or strategic disclosure in the provided text
Item EX-99.1 · Exhibit EX-99.1
- Chief Medical Officer Dr. John Anderson retiring at year-end after 33 years with Concentra
- Formal successor search underway, creating near-term leadership-transition risk in clinical strategy
- Anderson to advise Concentra under a consulting arrangement after departure
- Concentra serves approximately 53,000 patients daily across 628 centers and 411 onsite clinics
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Concentra Group Holdings Parent, Inc. 8-K filings
Get the next CON 8-K as it lands
Follow CON for push alerts, or ask the research agent what this filing means.